Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?
| dc.authorid | Bulut Gokten, Dilara/0000-0002-9226-7532 | |
| dc.contributor.author | Gokten, Dilara Bulut | |
| dc.contributor.author | Kavak, Fatma Yumun | |
| dc.contributor.author | Mercan, Ridvan | |
| dc.date.accessioned | 2024-10-29T17:59:43Z | |
| dc.date.available | 2024-10-29T17:59:43Z | |
| dc.date.issued | 2024 | |
| dc.department | Tekirdağ Namık Kemal Üniversitesi | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.doi | 10.46497/ArchRheumatol.2024.10564 | |
| dc.identifier.endpage | 478 | |
| dc.identifier.issn | 2618-6500 | |
| dc.identifier.issue | 3 | en_US |
| dc.identifier.startpage | 476 | |
| dc.identifier.trdizinid | #BAŞV! | |
| dc.identifier.uri | https://doi.org/10.46497/ArchRheumatol.2024.10564 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1273119 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.11776/14816 | |
| dc.identifier.volume | 39 | |
| dc.identifier.wos | WOS:001306098900005 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.language.iso | en | |
| dc.publisher | Turkish League Against Rheumatism | |
| dc.relation.ispartof | Archives of Rheumatology | |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Erythematosus | |
| dc.subject | Myelofibrosis | |
| dc.subject | Secondary | |
| dc.subject | Sle | |
| dc.title | Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus? | |
| dc.title.alternative | Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus? | |
| dc.type | Letter |
